Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

School districts across Minnesota are struggling to contain double-digit health insurance cost increases. Some officials say ...